Photobiomodulation Therapy Treatment on Facial Paralysis

Status Completed

Clinical Trial Summary

Objective: Facial paralysis can be caused by a variety of etiological factors, complete palsy continues for two months, the chance of full recovery is reduced to zero. The aim of this study was to evaluate the effectiveness of photobiomodulation therapy (PBMT) in the in patients undergoing facial paralysis over 8 weeks. Methods: This study was an open-label, not concurrent control study including 54 patients that underwent facial paralysis over 8 weeks. Patients were assigned to the PBMT group and control group, with 27 patients in each group. Laser treatments were applied 3 days a week after recruited. PBMT was delivered using a class IV Multi-wave Locked System that combines with a simultaneous 808 nm continuous emission and 905 nm pulse emission and the maximum peak power was 25 W. Clinical outcome measure comprised the House-Brackmann grading system, Facial Clinimetric Evaluation Scale (FaCE), Sunnybrook facial grading scale (SBFG), and electrophysiological testing, including Electroneuronography (ENoG), Electromyography (EMG) and Blink Reflex. All the measurements were collected at the first day and at the end of study. All reported P values were two-sided and were declared statistically significant when less than 0.05.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05585333
Study type	Interventional
Source	Beijing Tongren Hospital
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2021
Completion date	May 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01537952` - Microbiologic Findings of Acute Facial Palsy in Children	N/A
Recruiting	`NCT06335719` - Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome	N/A
Recruiting	`NCT04934176` - 3D Dynamic and Patient-Centered Outcomes of Facial Reanimation Surgery in Patients With Facial Paralysis
Completed	`NCT03974763` - Function and Form Outcomes in Patients With Facial Paralysis
Active, not recruiting	`NCT05997199` - The Effect Vitamin D on the Recovery Rate of Bell Palsy
Withdrawn	`NCT03622697` - Effects of Mindfulness Meditation on Facial Paralysis Patients	N/A
Terminated	`NCT05293522` - A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.	Phase 2
Completed	`NCT02988856` - Magnetic Correction of Eye Lid Paralysis	N/A
Completed	`NCT00989209` - Myofunctional Therapy in Facial Palsy	N/A
Enrolling by invitation	`NCT05945615` - Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis	Phase 3
Enrolling by invitation	`NCT04215562` - Outcome of Facial Palsy Following Rehabilitation	N/A
Recruiting	`NCT05191719` - Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy	N/A
Recruiting	`NCT03115203` - Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.	N/A
Completed	`NCT02527226` - Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors	N/A
Completed	`NCT04153916` - Artificial Eye Blinking Stimulation Following Paralysis of the Facial Nerve	N/A
Not yet recruiting	`NCT05222698` - Free Neurovascularized Muscle Transfer in Facial Reanimation of Long-standing Facial Palsy Patients	N/A